Skip to main content

Table 1 Clinical, hormonal and ultrasound data

From: Does polycystic ovarian morphology influence the response to treatment with pulsatile GnRH in functional hypothalamic amenorrhea?

 

FHA PCOM (n = 40)

FHA (n = 27)

p

Age (years)

28.5 [25.0–35.0]

28 [25.0–32.7]

NS

BMI (kg/m2)

18.5 [16.5–21.0]

18.1 [16.1–20.0]

NS

Clinical hyperandrogenism (%)

7.5 % (n = 3)

14.8 % (n = 4)

NS

LH (IU/L)

1.7 [0.5–3.9]

1.1 [0.5–3.6]

NS

FSH (IU/L)

4.9 [2.4–8.7]

5 [3.7–8.2]

NS

E2 (pmol/L)

80.7 [44.0–168.8]

73.4 [43.7–114.1]

NS

AMH (pmol/L)

51.0 [19.9–95.7]

18.4 [8.5–28.5]

<0,001

Follicle Number Per Ovary:

   

- before 2008

13.0 [7.5–19.3]

7.5 [3.0–10.0]

<0,001

- after 2008

17.5 [9.8–41.0]

9.0 [3.0–14.3]

<0,001

Ovarian area (cm2)

4.1 [2.3–5.8]

3.1 [1.5–4.8]

<0,001

TESTOSTERONE (nmol/L)

0.7 [0.3–2.8]

0.7 [0.3–1.7]

NS

DELTA 4 (nmol/L)

4.5 [2.1–9.4]

4.2 [2.4–7.7]

NS

DHEAS (μmol/L)

3.4 [1.4–6.3]

3.4 [1.8–5.7]

NS

  1. Values are medians with [5th–95th] percentiles